Protalix BioTherapeutics, Inc.PLXNYSE
LOADING
|||
Business Scale
Growth Engine
Valuation Context
Market Cap
$210M
Micro Cap
P/E (TTM)
38.4x
Elevated
P/S (TTM)
3.4x
In-line
EV/EBITDA
23.1x
Elevated
A smaller-scale business, operating profitably, with revenues declining priced at a premium.
Explore metrics